|Articles|December 15, 2004

Tauzin

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

PharmTech Weekly Roundup—June 12, 2026

BySusan Haigney

June 12th 2026

European Union Healthcare: A close-up of white and red capsules symbolizing healthcare against a backdrop of the European Union flag, signifying health and well-being in a European context. | Image Credit: ©pattozher -stock.adobe.com

EMA Approved 104 Human Medicines in 2025

BySusan Haigney

June 11th 2026

Q&A: Molly Klote on Dual Sourcing, Regionalization, and the New Pharma Normal

ByMolly Klote,Zachary Zubulake

June 11th 2026

Patient Access to Radiopharmaceuticals

ByNicholas Richardson,Susan Haigney

June 10th 2026

Demand surge and supply critical issues highlight healthcare system overload with scattered medicine pills on wooden surface under warm light | Image Source: ©Enjoy -stock.adobe.com

USP Reports Drug Discontinuations on the Rise

BySusan Haigney

Published: June 9th 2026 | Updated: June 10th 2026

Tauzin

Related Content

PharmTech Weekly Roundup—June 12, 2026

EMA Approved 104 Human Medicines in 2025

Q&A: Molly Klote on Dual Sourcing, Regionalization, and the New Pharma Normal

Patient Access to Radiopharmaceuticals

USP Reports Drug Discontinuations on the Rise

Trending on Pharmaceutical Technology

Overcoming Fill-Finish Capacity Bottlenecks in Automated Pen Injector Assembly Lines

EMA Approved 104 Human Medicines in 2025

PharmTech Weekly Roundup—June 12, 2026

GSK's Momelotinib Pursues Rare VEXAS Syndrome Indication

Optimizing Impact for Rare Diseases